Drug Shortages in Albania: Pharmacists' Experiences and Perspectives.

Delina Xhafaj, Sonila Vito, Alban Xhafaj
Author Information
  1. Delina Xhafaj: Department of Pharmacy, Faculty of Medical Science, Albanian University, 1001 Tirana, Albania. ORCID
  2. Sonila Vito: Department of Pharmacy, Faculty of Medical Science, Albanian University, 1001 Tirana, Albania.
  3. Alban Xhafaj: Department of Data and Digitalization, Intrum S.P.A., 20121 Milan, Italy.

Abstract

Drug shortages are a significant global issue, particularly affecting healthcare systems in resource-limited countries such as Albania. Pharmacists play a critical role in managing these shortages, yet little is known about their experiences and perspectives. This study aims to explore pharmacists' views on the current drug shortages in Albania, identifying the most affected drug classes, and suggesting potential strategies for mitigating these shortages. A cross-sectional survey was conducted with 93 pharmacists across Albania between December 2023 and May 2024. Data were collected using an online questionnaire that addressed the types of drugs experiencing shortages, the causes of these shortages, and pharmacists' coping strategies. Cardiovascular and central nervous system medications were reported as the most frequently affected, with supply chain disruptions, regulatory hurdles, and low domestic production cited as key contributors. The findings suggest an urgent need for national policy reforms focusing on improving supply chain resilience and boosting the local pharmaceutical production. The pharmacists proposed mitigation strategies, including stricter regulatory oversight, improved communication channels, and increased local production to reduce dependence on imports. These recommendations underscore the study's contribution to understanding how tailored, pharmacist-informed strategies could strengthen Albania's healthcare system.

Keywords

References

  1. Am J Health Syst Pharm. 2011 Oct 1;68(19):1811-9 [PMID: 21930639]
  2. Health Policy. 2020 Dec;124(12):1287-1296 [PMID: 33032846]
  3. Br J Clin Pharmacol. 2023 Oct;89(10):2950-2956 [PMID: 37455356]
  4. Br J Clin Pharmacol. 2023 Oct;89(10):2957-2963 [PMID: 37455465]
  5. Front Pharmacol. 2021 Jul 09;12:693426 [PMID: 34305603]
  6. Hosp Pharm. 2015 Apr;50(4):279-86 [PMID: 26448658]
  7. Pharmacy (Basel). 2024 Sep 06;12(5): [PMID: 39311127]
  8. Pharmacy (Basel). 2023 Jul 21;11(4): [PMID: 37489351]
  9. Pharmacy (Basel). 2024 Aug 28;12(5): [PMID: 39311123]
  10. Daru. 2020 Dec;28(2):799-805 [PMID: 32617864]
  11. BMC Public Health. 2014 Jul 30;14:767 [PMID: 25073407]
  12. Health Policy. 2015 Feb;119(2):232-8 [PMID: 25467285]
  13. JCO Oncol Pract. 2022 Aug;18(8):e1289-e1296 [PMID: 35544740]
  14. Pharmacy (Basel). 2023 Oct 18;11(5): [PMID: 37888510]
  15. J Am Pharm Assoc (2003). 2022 May-Jun;62(3):791-799.e2 [PMID: 35115262]
  16. Eur J Hosp Pharm. 2024 Feb 2;: [PMID: 38307707]

Word Cloud

Created with Highcharts 10.0.0shortagesAlbaniastrategieshealthcaredrugpharmacistssupplychainproductionDrugpharmacists'affectedsystemregulatorylocalsignificantglobalissueparticularlyaffectingsystemsresource-limitedcountriesPharmacistsplaycriticalrolemanagingyetlittleknownexperiencesperspectivesstudyaimsexploreviewscurrentidentifyingclassessuggestingpotentialmitigatingcross-sectionalsurveyconducted93acrossDecember2023May2024DatacollectedusingonlinequestionnaireaddressedtypesdrugsexperiencingcausescopingCardiovascularcentralnervousmedicationsreportedfrequentlydisruptionshurdleslowdomesticcitedkeycontributorsfindingssuggesturgentneednationalpolicyreformsfocusingimprovingresilienceboostingpharmaceuticalproposedmitigationincludingstricteroversightimprovedcommunicationchannelsincreasedreducedependenceimportsrecommendationsunderscorestudy'scontributionunderstandingtailoredpharmacist-informedstrengthenAlbania'sShortagesAlbania:Pharmacists'ExperiencesPerspectives

Similar Articles

Cited By